Meropenem

🧮 Dose calculator

Skin and skin structure infection · Regimen source: FDA Meropenem · 2.1

• • 1 g every 8 h if Pseudomonas aeruginosa is suspected or confirmed. FDA Meropenem · 2.1

Enter age and weight.

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Meropenem · 8.1

  “Risk Summary There are insufficient human data to establish whether there is a drug-associated risk of major birth defects or miscarriages with meropenem in pregnant women.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Meropenem · 8.2

  “Risk Summary Meropenem has been reported to be excreted in human milk.”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Meropenem · 8.4

  “The safety and effectiveness of Meropenem for injection have been established for pediatric patients 3 months of age and older with complicated skin and skin structure infections and bacterial meningitis, and for pediatric patients of all ages with complicated intra-abdominal infections.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Meropenem · 8.5

  “Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.